Extract NASA Medical Tech Licensing Economics via FOIA Database
- Organization
- NASA Technology Transfer Program
- Sector
- Investment Firms, IP Brokers, Medical Device Companies
- Location
- United States
Source reference
Executive summary
Current state
NASA's Technology Transfer Program holds three flight-qualified medical diagnostic patents with proven commercial interest but suffers from institutional pricing inefficiencies and lack of commercial optimization capacity, creating multiple asymmetric exploitation vectors.
Market catalyst
NASA's Technology Transfer Program has executed licensing agreements with specific financial terms (royalty rates, upfront fees, performance milestones) for three high-value medical technologies, but these terms are buried in FOIA-accessible documents rather than publicly disclosed, creating an intelligence gap that can be monetized
This report is synthesized intelligence, not verified instruction. Always confirm against the primary source before acting. Review the full legal disclaimer before proceeding.
Field notes
Intelligence ledger
Add new evidence, corrections, or practical context to this directive. Keep claims attributable to a source where possible.
Sign in to add intelligence or vote on a field note.
Field intel logs: [ 0 ] entries. No operative updates submitted for this directive. Submit intel to claim clearance.